BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11127080)

  • 21. Early differential diagnosis of multiple sclerosis using a new oligoclonal band test.
    Villar LM; Masjuan J; Sádaba MC; González-Porqué P; Plaza J; Bootello A; Alvarez-Cermeño JC
    Arch Neurol; 2005 Apr; 62(4):574-7. PubMed ID: 15824255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sensitized immunofixation: a new technique for analyzing the oligoclonal pattern of CSF immunoglobulins].
    Desplat S; Pelletier J; Pouget J; Bellon F; Bernard D; Boucraut J
    Rev Neurol (Paris); 2000 Oct; 156(10):885-9. PubMed ID: 11033517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biologic markers in multiple sclerosis (and II). Neurophysiologic and imaging correlations].
    Dapena D; Castillo J; Corredera E; Lema M; Noya M
    Neurologia; 1992 Oct; 7(8):216-22. PubMed ID: 1449838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of isoelectric focusing of cerebrospinal fluid immunoglobulin G in the early biological assessment of multiple sclerosis].
    Caudie C; Allauzen O; Bancel J; Later R
    Ann Biol Clin (Paris); 2000; 58(2):187-93. PubMed ID: 10760705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intrathecal oligoclonal and polyspecific immune response in multiple sclerosis].
    Robinson Agramonte MA; Reiber H; Dorta Contreras AJ; Hernández Díaz E
    Rev Neurol; 2001 Nov 1-15; 33(9):809-11. PubMed ID: 11784982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relevance of immunological variables in neuroborreliosis and multiple sclerosis.
    Bednárová J; Stourac P; Adam P
    Acta Neurol Scand; 2005 Aug; 112(2):97-102. PubMed ID: 16008535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analytical performances of SPAPLUS® turbidimeter for the quantification of albumin and IgG in serum and cerebrospinal fluid.
    Benard C; Chauzeix J; Blancher A; Puissant-Lubrano B
    Clin Biochem; 2016 Jul; 49(10-11):828-31. PubMed ID: 27048976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein gradients in the cerebrospinal fluid and the calculation of intracerebral IgG synthesis.
    Wurster U
    J Neuroimmunol; 1988 Dec; 20(2-3):233-5. PubMed ID: 3198747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of seven formulae and isoelectrofocusing for determination of intrathecally produced IgG in neurological diseases.
    Ohman S; Ernerudh J; Forsberg P; Henriksson A; von Schenck H; Vrethem M
    Ann Clin Biochem; 1992 Jul; 29 ( Pt 4)():405-10. PubMed ID: 1642446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preliminary study on immunoglobulins G in the cerebrospinal fluid of neurological patients].
    Cognazzo A; Grasso E
    Minerva Med; 1977 May; 68(22):1531-5. PubMed ID: 870857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.
    Bartosik-Psujek H; Archelos JJ
    J Neurol; 2004 Apr; 251(4):414-20. PubMed ID: 15083285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of virus-specific intrathecally synthesised immunoglobulin G with a fully automated enzyme immunoassay system.
    Schubert J; Weissbrich B
    BMC Neurol; 2007 May; 7():12. PubMed ID: 17535416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunonephelometric determination of proteins in cerebrospinal fluid in various neurological disorders.
    Baark JP; Berg O; Hemmingsen L
    Clin Chim Acta; 1983 Jan; 127(2):271-7. PubMed ID: 6337755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis of multiple sclerosis].
    Yang CC
    Acta Neurol Taiwan; 2005 Dec; 14(4):213-20. PubMed ID: 16425550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the diagnostic value of different CSF investigations in multiple sclerosis.
    Lauer K
    J Neurol; 1984; 231(3):130-4. PubMed ID: 6481418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fibronectin as a diagnostic marker in several determined neurological diseases].
    Merino García LC; González Sarmiento E; Rubio del Val MC; Ergueta Martín P; Hinojosa Mena-Bernal MC; Fernández Martínez I; Marañón Cabello A
    An Med Interna; 2000 Aug; 17(8):406-9. PubMed ID: 11218986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement.
    Freedman MS; Thompson EJ; Deisenhammer F; Giovannoni G; Grimsley G; Keir G; Ohman S; Racke MK; Sharief M; Sindic CJ; Sellebjerg F; Tourtellotte WW
    Arch Neurol; 2005 Jun; 62(6):865-70. PubMed ID: 15956157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetranectin in cerebrospinal fluid of patients with multiple sclerosis.
    Stoevring B; Jaliashvili I; Thougaard AV; Ensinger C; Høgdall CK; Rasmussen LS; Sellebjerg F; Christiansen M
    Scand J Clin Lab Invest; 2006; 66(7):577-83. PubMed ID: 17101549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrepancies between qualitative and quantitative analysis of cerebrospinal fluid IgG: densitometric comparison of nephelometry-silver versus immuno-enzymes.
    Keir G; Barrio S; Thompson EJ
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):404-8. PubMed ID: 18583626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.